A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1
Behavioral Trial for the Treatment of Methamphetamine Dependence
1 other identifier
interventional
50
1 country
5
Brief Summary
The purpose of this study is to examine behavioral treatment for methamphetamine dependence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jul 2001
Shorter than P25 for phase_2
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2001
CompletedFirst Submitted
Initial submission to the registry
April 5, 2002
CompletedFirst Posted
Study publicly available on registry
April 8, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2002
CompletedJanuary 11, 2017
August 1, 2003
April 5, 2002
January 10, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Withdrawal symptoms
New Use algorithm
Interventions
Eligibility Criteria
You may qualify if:
- Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence.
You may not qualify if:
- Additional criteria available during screening at the site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
South Bay Treatment Center
Chula Vista, California, 91911, United States
Matrix Institute on Addictions
Costa Mesa, California, 92627, United States
John A. Burns School of Medicine
Honolulu, Hawaii, 96813, United States
Powell Chemical Dependency Center
Des Moines, Iowa, 50316, United States
Comprehensive Mental Health Services, Inc
Independence, Missouri, 64052, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Rawson, Ph.D.
National Institute on Drug Abuse (NIDA)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
April 5, 2002
First Posted
April 8, 2002
Study Start
July 1, 2001
Study Completion
June 1, 2002
Last Updated
January 11, 2017
Record last verified: 2003-08